IGC Pharma, Inc.

US$0.20As of Sun 8 Nov 2026, 12:00 UTC
AMEX:IGCHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (7.08%)
Div yield —
ROE (83.34%)
Biotechnology
Beta (5Y) 0.55
PE TTM —
TSR TTM (49.41%)
Mkt cap US$20.68M
ROIC (63.56%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.224
11.95%
26.67%
Hold 7|12|1|7|8
3Q26
4Q26
1Q27
2Q27
Earnings per share$
—
—
—
—
19.88%
12.18%
9.47%
14.55%
Revenue$M
1.262
1.334
1.331
1.392
12.23%
13.32%
7.19%
9.27%
Peers (US$20.68M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.923
(0.293)
(0.246)
EBIT/Intx
2.089
0.520
0.461
Own earn%
27.12
164.68
144.64
Sh yield%
40.01
27.07
26.07
Owners
Insiders/Inst%
5.98
79.13
Short interest%
2.65
SBC / revenue%
5.44
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
0–5
$1 testx
—
Incr. ROIC%
3